Benzodiazepines are an important class of drugs commonly administered with a potential for abuse and environmental pollution. This review focuses on the liquid chromatographic electrochemical detection of the benzodiazepine class of drugs. These are characterised by a readily electrochemically reducible azomethine group, with a number also substituted by other electrochemically active groups. Liquid chromatography employing both single and dual electrode detection has been reported for a variety of benzodiazepines and their metabolites in biological, pharmaceutical, biomedical and forensic investigations. Recently, electrochemistry has been utilised to mimic biological oxidation processes and has been combined with liquid chromatography/mass spectroscopy for their identification and quantification of the products generated. The present review focuses on recent developments in liquid chromatographic-electrochemical determination of benzodiazepines reported since 2006, with earlier reports given in summary.
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However, for some time there has been a degree of controversy regarding the use of benzodiazepines [2, 3, 7, 8] as prolonged use can result in increased tolerance, physical dependence and withdrawal symptoms; in addition overdoses result in symptoms such as respiratory depression or coma. Reviews [9, 10] have highlighted other issues, especially with the elderly, with increased reports of falls and a resulting increased incidence of hip fractures and risk of cerebrovascular events and deaths.
Due to their wide pharmaceutical applications, and subsequent disposal, concern has also arisen regarding other areas effecting the wider population. Reports have highlighted their use in drugfacilitated crime (DFC), drug-facilitated sexual assaults (DFSA) [11] [12] [13] and abuse [2, 8] . Detectable levels have also been recently reported in potable and environmental water systems, resulting in possible toxic effects for both humans and aquatic life [14] [15] [16] . Consequently, there is a pressing demand for methods capable of determining trace levels of benzodiazepines in both environmental and medical biological samples. Common analytical approaches utilised for the determination of benzodiazepines, such as, gas chromatography [17] , immunoassay [17] [18] [19] , liquid chromatography [19] [20] [21] and spectroscopy [22] have been reported. However, the application of liquid chromatography with electrochemical detection for the analysis of this group of drugs has not been recently reviewed. In this article we review such developments since 2006.
The Electrochemical Behaviour of Benzodiazepines
The 1,4-benzodiazepine class of drugs are characterised by a relatively easily reducible azomethine group; a number also contain other electrochemically active groups such as, nitro, N-oxide and carbonyl groups. The 2e -, 2H
+ electrochemical reduction of the azomethine group results in the corresponding dihydro derivative (eq. 1) [23] .
R-C=N-R' + 2e -+ 2H + → R-(H)C-N(H)-R' (eq.1)
Many of the 1,5-benzodiazepines, such as clobazam are reported to be electrochemically inactive [24] . However, some, such as the 3H-1,5-benzodiazepines [25] have been shown to undergo two 2e -, 2H + reductions at their azomethine groups. The dibenzo substituted benzodiazepines such as clozapine (scheme I) undergo a reversible 2e -, H + redox reaction involving a relatively stable nitrenium ion [26, 27] .
Scheme I
ISSN 1664-171X ISSN 1664-171X Table 1 . Pre-2006 applications of liquid chromatography coupled with electrochemical detection for the determination of benzodiazepines These redox processes have been shown to occur with a variety of electrode materials and as a result a range of different electrochemical techniques, including polarography and voltammetry have been successfully utilised. These have been shown to be sensitive, economic and flexible and have been exploited for the determination of a range of parent benzodiazepines and their metabolites in complicated matrices such as blood [28] [29] [30] , and forensic samples [31] [32] [33] [34] . Utilising techniques such as adsorptive stripping voltammetry [35] detection limits in the nM to µM range are readily obtainable. Some recent reports describe the application of ion selective electrodes [36] [37] [38] [39] and electrochemical biosensors [40, 41] for the determination of benzodiazepines. Electrochemical detection can be readily employed with flow injection analysis and liquid chromatography employing both single and dual electrode detection systems. Recent studies have illustrated the possibility of using electrochemistry to simulate drug metabolism and has been coupled to mass spectroscopy for product identification.
This review focuses on liquid chromatography coupled with electrochemically based techniques for the determination of the benzodiazepine class of drugs. Liquid chromatographic approaches using both single and dual electrode detection are included as well as electrochemical derivatisation in conjugation with mass spectroscopy. Details of methodology, design and performance of selected 
Liquid Chromatography Electrochemical Detection of Benzodiazepines
Many benzodiazepines are known to be thermal unstable and form common degradation products. As a result techniques such as liquid chromatography which can be undertaken at ambient or near ambient temperatures are popular methods for the separation and quantification of these drugs [21, 47, 48] . Recently, Trojanowicza has reviewed the utilisation of electrochemical detection with both flow injection analysis [49] and liquid chromatography [47] for a range of compounds. The underlying theory and applications including the determination of several benzodiazepines was described [43, [50] [51] [52] . Attention first focused on LC-ED with regard to neurochemical problems, leading to the first commercially available detectors being produced in 1974 [52] . These systems had several advantages including enhanced selectivity, low detection limits and low cost.
Normal phase chromatography cannot generally be utilised as nonpolar solvents are not suitable for use with common buffers. However, recent studies have shown the possibility of utilising related techniques such as hydrophilic interaction liquid chromatography with electrochemical detection [53] . Table 1 gives a summary of the liquid chromatographic approaches that have been reported prior to 2006. A variety of different approaches has been described including coulometric and amperometric and dual electrode systems. Both Hg and carbon based working electrodes have been employed successfully for benzodiazepine determination in complex samples such as blood, milk and tissue. More recently, Martins et al [54] have reported on the determination of diazepam, clonazepam, flunitrazepam and nitrazepam using boron doped diamond electrode (BDDE), as part of a liquid chromatographic system. Cyclic voltammetry was employed to investigate the electrochemical behaviour of the four benzodiazepines at the BDDE in 0.1 M phosphate buffer at pH 3.5, 6.0 and 8.0 with the optimum response obtained at pH 3.5. Chromatographic separation was achieved using an octyldecyl stationary phase in conjugation with a mobile phase comprising sodium phosphate (pH 3.5; 0.10 M) acetonitrile (65:35, v/v), at a flow rate of 1.2 ml/min. A thin layer amperometric detector operated in the pulse mode was used for the detection of the benzodiazepines. The optimum wave form for the reduction was reported to be -1.9 V, +1.5 V and -0.5 V, with repetition time of 0.5 s. Detection limits of 0.5, 0.6 and 2.0 µg/ml were reported for nitrazepam, clonazepam and diazepam respectively. Analysis of pharmaceutical tablet formulations showed good agreement with that found by liquid chromatography with UV diode array detection.
Applications
Liquid chromatography dual electrode detection (LC-DED) has been shown to be a powerful analytical technique and has been utilised for the determination of a number of benzodiazepines (table  1) . Recently, LC-DED in the redox mode has recently been explored by Honeychurch et al [55] for the determination of nitrazepam in serum. In this approach, two electrochemical cells are arranged in series after the analytical chromatographic column. The first upstream cell is used as the "generator" cell to reduce nitrazepam to the corresponding hydroxylamine species, which is then detected at the
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ISSN 1664-171X second downstream "detector" cell via oxidation to the corresponding nitroso species. The advantage of this approach is that the electrochemically generated product is much more readily oxidized or reduced than the parent compound; consequently lower applied potentials are required for its determination, so allowing for improvements in selectivity of the system, as the detector potential is operated at a lower applied potential. The sensitivity of the system is also improved as a result of the lower background currents occurring at the detector electrode compared with those obtained at the high potentials required for direct electrochemical detection. This can be readily seen in figure 2 , where chromatograms obtained for fixed 300 ng injections of nitrazepam using the reductive mode and DED mode detection techniques are shown. As can be readily seen, the best signal-to-noise ratio was obtained by using the redox mode ( figure 2b and 2c) . Incidentally, it was found impossible to operate the detector at low nA ranges in the direct reductive mode, (figure 2a) due to excessive baseline drift; this probably arises from the ingress of oxygen into the mobile phase even though degassing was performed continuously. In addition, an unresolved pre-peak was seen in the reductive mode (figure 2a); this would result in significant errors when calculating nitrazepam levels in serum samples. Such effects demonstrate the superior analytical responses that can be obtained using DED. Using LC-DED, nitrazepam levels in both human and bovine serum could be successfully determined following a simple, rapid sample preparation step. A mean recovery of 74 % (%CV = 7.8 %) was obtained for a human serum sample fortified with 1670 ng/ml nitrazepam.
More recently, a variation on this technique for the determination of both nitrazepam, and flunitrazepam, in beverage samples such as Pepsi Max ® has been reported by Honeychurch and Hart [56] . In this approach a carbon fibre veil electrode (CFVE) was incorporated as the generator electrode to increase the conversion efficiency of this flow cell. Cyclic voltammetric studies were performed to ascertain the redox behaviour of nitrazepam and flunitrazepam at a CFVE in the optimised mobile phase. As can be seen in figure 3 , cyclic voltammetric behaviour of the two compounds was similar to that obtained with a GCE. Interestingly, a novel reduction-reduction LC-DED approach could be exploited to measure these two nitro containing drugs. The initial reduction reaction occurring at the at the generator electrode was postulated to result from a two 2e , 2H + reduction of the 7-nitro group first to the corresponding nitroso species, with the associated loss of water. This was then followed by a further 2e -, 2H + reduction at the detector electrode to the corresponding hydroxylamine. A linear range of 2.0 to 100 μg/ml, with a detection limit of 20 ng/ml was obtained. Only a simple sample extraction procedure was required prior to analysis using the optimised LC-DED procedure. A mean recovery of 95.5% (%CV = 4.5%) for nitrazepam and 78.0% (%CV = 8.8%) was achieved for a beverage sample spiked at 1.0 μg/ml nitrazepam and 1.47 μg/ml flunitrazepam.
ISSN 1664-171X Saracino et al [57] have reported the application of high-performance liquid chromatography with both coulometric and diode array detection for the therapeutic drug monitoring of patients with bipolar disorders; the patients were treated with olanzapine and lamotrigine. Chromatographic separation was achieved with a reversed-phase C 8 column (150 x 4.6 mm, 5 µm) using a mobile phase composed of methanol (27%) and a 50.0 mM, pH 3.5 phosphate buffer (73%). For the analysis of olanzapine and its main metabolite, N-desmethylolanzapine, a dual coulometric detector was used, with the first downstream electrode 1 set at -200 mV and the subsequent upstream electrode 2 at +500 mV. Lamotrigine was determined using diode array detection at 220 nm with the two detectors connected in series. For the analysis of biological samples, a clean-up procedure was implemented by means of solid-phase extraction using phenyl cartridges and eluting the analytes with methanol. Recoveries greater than 90%, with an associated precisions of <3.4% were reported. Linear responses were obtained between 0.1 and 50.0 ng/ml for olanzapine, 0.1 and 25.0 ng/ml for N-desmethylolanzapine, and between 0.25 and 10.0 µg/ml for lamotrigine. The method was applied successfully to some human plasma samples drawn from bipolar patients undergoing combined therapy with the two drugs.
ISSN 1664-171X In an alternative approach, Kobylińska et al [58] successfully utilised HPLC with amperometric detection at +0.6 V for the determination of olanzapine in human plasma with a glassy carbon working electrode, cleaned by pulsing the applied potential. Blood was collected from volunteers and centrifuged at 3500 rpm the separated plasma was decanted and ascorbic acid was added to protect the olanzapine from oxidation. The internal standard, clozapine was then added to 0.5 ml of the resulting plasma sample and after the addition of 0.25 ml of 40 mM sodium carbonate, extracted with 2 ml of ethyl acetate, by shaking for 5 minutes. The two phases were separated by holding the sample/solvent mixture at -70 ºC for 10 minutes. The resulting organic phase was then evaporated to dryness and reconstituted in a mixture of 200 µl of methanol and 200 µl of 0.06 M ammonium acetate. This was ISSN 1664-171X then mixed and introduced to the HPLC system. Separations were achieved using a 125 x 4.0 mm, 5 µm C 18 column with a mobile phase of 0.06 M ammonium acetate buffer, pH 5.9, acetonitrile and methanol at flow rate of 0.69 ml/min. The method was able to determine olanzapine plasma concentrations after the administration of one 10 mg oral dose over a period of 120 hours. A linear response over the range 0.313-25.00 ng/ml was reported, the former being the limit of quantification.
Recently, Honeychurch et al [59] successfully exploited a previously unreported electrochemical redox reaction for flunitrazepam, lorazepam and diazepam for their determination in serum by LC-DED. The initial cyclic voltammetric investigation represented the first report on the anodic behaviour of diazepam and lorazepam. Previous reports had only recorded the reduction of the 4,5-azomethine group, with no further redox peaks reported. However, in this study, new oxidation peaks were recorded which did not occur without prior reduction of the molecule. These redox processes were investigated for the possible LC-DED determination. Studies were performed to optimise the chromatographic conditions and were found to be 50 % acetone, 50 % 100 mM pH 2 phosphate buffer at a flow rate of 0.8 ml/min, employing a Hypersil C 18 , 5 µm, 250 mm x 4.6 mm column held at 40 °C using a generator potential of -2.4 V (vs. stainless steel) and detector potential of +1.0 V (vs. Ag/AgCl). Enhancement in both peak height and peak area (coulombs) was seen with decreasing flow rate, probably resulting from improvements in the electrolytic conversion efficiency of the cell at lower flow rates. This decrease in flow rate results in a higher conversion of the analyte at the working electrode and consequently, larger peak areas (coulombs) are expected. Figure 4 shows the resulting chromatograms obtained under the optimised conditions for fortified and unfortified bovine serum. 
Combined On-line Electrochemistry/ Mass Spectrometry Analysis
Recently reports have shown the possibility of utilising on-line electrochemistry/mass spectrometry (EC/MS) as a rapid economic method for early-stage drug metabolite discovery and to anticipate biological oxidation patterns. Baumann et al [77] have utilised LC-MS in series with an electrochemical wall-jet generator electrode to model the metabolic pathway of tetrazepam. The electrochemical results were compared to results from microsomal incubations, and to those generated Insciences Journal | Sensors by in vivo studies obtained with urine samples from a patient after tetrazepam delivery ( Figure 5 ). The tetrazepam sample was injected into the electrochemical wall-jet cell by syringe pump; the applied potential was +2.0 V. The resulting electrochemically generated oxidation products were then separated and determined by LC-MS. A number of metabolites were identified, including nortetrazepam and 3-hydroxytetrazepam and notably diazepam. Earlier studies by Mouithys-Mickalad et al [78] and van Leeuwen [27] utilised a similar approach to study the metabolism of clozapine. These authors employed different applied potentials to a porous carbon electrode, and were able to generate a variety of hydroxylated and demethylated species. Hydroxylated species were reported to be most abundant using a potential of +0.4 V, with demethylated species being produced at +0.7 V (vs. Pd/H 2 ). The addition of reduced glutathione was found to result in the formation of a number of isomeric glutathione adducts, reportedly similar to that described in the literature for phase I and II metabolism.
Conclusion
The benzodiazepines class of drugs have a long history of pharmaceutical usage and are still commonly used medically for a number of conditions. However, reports have described their use in criminal activity and their contamination of the environment has now become now a more commonly reported problem. The realisation that benzodiazepines are characterised by a facile electrochemically reducible azomethine group, with a number also containing other electro-active groups, such as, nitro, hydroxyl and N-oxide has resulted in their determination using electrochemical detection methods following HPLC with a range of different electrode materials.
Applications for the liquid chromatographic electrochemical determination of 1,4-benzodiazepines have utilised both reductive and more recently dual electrode modes of detection. Both approaches allow for low detection limits, and have been shown to be applicable for the determination complicated samples, such as serum and forensic samples. However, the reductive mode has been shown to suffer from common interferences, such as oxygen.
New analytical developments will continue to be made for other areas other than medical and pharmaceutical analysis, such as in forensic and environmental analysis and has already been shown for the simulation of drug metabolism. The development of new benzodiazepines and related drugs, such as zaleplon and zolpidem will also drive the further developments of electrochemical assays for this important class of drugs.
